Episodi

  • Host: Perry Elliott

    Guest: Hector Bueno

    Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1796?resource=interview

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests:

    Hector Bueno has declared to have potential conflicts of interest to report: research funding from the European Union (EU4H-2022-JA-03), Instituto de Salud Carlos III, Spain (FORTALECE program, PI21/01572), Sociedad Española de Cardiología, AstraZeneca, Boehringer Ingelheim, Janssen, and Novartis; and has received in the past consulting/speaking fees from Astra-Zeneca, Novartis, Novo Nordisk and Organon.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies Hypertensive disorders during pregnancy Depression and heart disease Mythbusters: "The French Paradox"

    Host: Perry Elliott

    Guests: Carlos Aguiar, Martha Gulati, Hector Bueno

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1796

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests:

    Stephan Achenbach, Martha Gulati, Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Hector Bueno has declared to have potential conflicts of interest to report: research funding from the European Union (EU4H-2022-JA-03), Instituto de Salud Carlos III, Spain (FORTALECE program, PI21/01572), Sociedad Española de Cardiología, AstraZeneca, Boehringer Ingelheim, Janssen, and Novartis; and has received in the past consulting/speaking fees from Astra-Zeneca, Novartis, Novo Nordisk and Organon.

    Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

  • Episodi mancanti?

    Fai clic qui per aggiornare il feed.

  • Host: Emer Joyce

    Guest: Harald Jorstad

    Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1795?resource=interview

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests:

    Harald Jorstad has declared to have potential conflicts of interest to report: unrestricted research grants to institution: Dutch Olympic Committee, Dutch Heart Foundation, Zon-Mw, Heart to Handle. Unrestricted, unrelated research grants to institution: Novartis, Amarin, Novo Nordisk, Sanofi. Unrelated advisory fees to institution: Amarin, Amgen.

    Emer Joyce has declared to have no potential conflicts of interest to report.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies Aortic aneurysms Return to elite sports after a severe cardiac event Milestones: CAST

    Host: Emer Joyce

    Guests: Carlos Aguiar, Jose Rodriguez Palomares, Harald Jorstad

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1795

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests:

    Stephan Achenbach, Emer Joyce, Nicolle Kraenkel and Jose Rodriguez Palomares have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo.

    Harald Jorstad has declared to have potential conflicts of interest to report: unrestricted research grants to institution: Dutch Olympic Committee, Dutch Heart Foundation, Zon-Mw, Heart to Handle. Unrestricted, unrelated research grants to institution: Novartis, Amarin, Novo Nordisk, Sanofi. Unrelated advisory fees to institution: Amarin, Amgen.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies

    Heart disease in dialysis patients

    Substance abuse and heart disease

    Snapshots: Pneumopericardium

    Host: Emer Joyce

    Guests: Carlos Aguiar, Patrick Mark, Theo Pezel, Stephan Achenbach

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1794

    Disclaimer:

    ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests:

    Stephan Achenbach, Emer Joyce, Nicolle Kraenkel and Theo Pezel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo.

    Patrick Mark has declared to have potential conflicts of interest to report: lecture/advisory board honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Pharmacosmos, Astellas, GSK, Vifor. Grants from Boehringer Ingelheim, AstraZeneca.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

  • Host: Perry Elliott

    Guest: Christiaan Vrints

    Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1793?resource=interview

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Christiaan Vrints has declared to have no potential conflicts of interest to report.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies

    Optimal management of angina

    Artificial sweeteners and cardiovascular risk

    Statistics Made Easy: Network meta-analyses

    Host: Perry Elliott

    Guests: Carlos Aguiar, Christiaan Vrints, Marco Witkowski

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1793

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Antonio Greco, Nicolle Kraenkel, Christiaan Vrints and Marco Witkowski have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies The why and how of MRAs in Heart Failure Managing electrical storm Mythbusters: garlic protects from the heart

    Host: Perry Elliott

    Guests: Carlos Aguiar, Sana Al-Khatib, Rudolf de Boer

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1792

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb.

    This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Sana Al-Khatib and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo.

    Rudolf de Boer has declared to have potential conflicts of interest to report: direct research funding from European Research Council (ERC), Netherlands Heart Foundation, Fondation leDucq, Netherlands Organization for Scientific Research. Research funding to department or institution: AstraZeneca, Abbott, Boehringer Ingelheim, Cardior Pharmaceuticals GmbH, NovoNordisk. Direct fees from Abbott, AstraZeneca, Cardior Pharmaceuticals GmbH, NovoNordisk, Roche Diagnostics. Fees to department or institution: NovoNordisk.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc., Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology this Week: A concise summary of recent studies Strategic decisions in atrial fibrillation Critical evaluation of clinical trials Snapshots

    Host: Perry Elliott

    Guests: Stephan Achenbach, Carlos Aguiar, Jane Armitage, Isabel Deisenhofer

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1720

    Disclaimer

    ESC TV Today is supported by Bristol Myers Squibb. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Jane Armitage and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi Aventis, Novo Nordisk, Terumo.

    Isabel Deisenhofer has declared to have potential conflicts of interest to report: speaker honoraria and travel grants from Abbott Medical, Biosense-Webster, Boston Scientific, BMS, Volta Medical, and research grant (for the institution) from Abbott Medical and Daiichi Sankyo.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics, AstraZeneca, Forbion.

    Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging, Inc., Calgary, Alberta, Canada.

    Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies What is new in lipid management – therapeutic options beyond statins Cardiac papillary fibroelastomas Snapshots

    Host: Rick Grobbee

    Guests: Stephan Achenbach, Carlos Aguiar, Kyle Klarich, Konstantinos Koskinas

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1157

    Disclaimer

    ESC TV Today and ESC 365, the cardiology knowledge hub are supported by Bristol Myers Squibb.

    The scientific content and opinions expressed in this programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Rick Grobbee, Kyle Klarich and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.

    Konstantinos Koskinas has declared to have potential conflicts of interest to report: speaker fees / honoraria from Amgen, Daiichi-Sankyo, Sanofi.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies Drug treatment of hypertrophic cardiomyopathy Humour in medicine Statistics Made Easy: Regression analysis

    Host: Susanna Price

    Guests: Carlos Aguiar, Milind Desai, Rohin Francis

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1156

    Disclaimer:

    ESC TV Today and ESC 365, the cardiology knowledge hub are supported by Bristol Myers Squibb.

    The scientific content and opinions expressed in this programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Rohin Francis, Antonio Greco, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Milind Desai has declared to have potential conflicts of interest to report: consultant and research agreements with Bristol Myers Squibb, Tenaya, Edgewise, Cytokinetics and VIZ AI.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology this Week: A concise summary of recent studies Lifetime management of aortic valve stenosis Spirituality and cardiovascular health Statistics Made Easy: Statistical Analyses using Chat GPT

    Host: Perry Elliott

    Guests: Carlos Aguiar, Kavitha Chinnaiyan, Francesco Maisano

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1155

    Disclaimer

    ESC TV Today and ESC 365, the cardiology knowledge hub are supported by Bristol Myers Squibb. The scientific content and opinions expressed in this programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Kavitha Chinnaiyan and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Giuseppe Biondi-Zoccai has declared to have potential conflicts of interest to report : Aleph, Amarin, Balmed, Cardionovum, Crannmedical, Endocore Lab, Eukon, Guidotti, Innovheart, Meditrial, Menarini, Microport, Opsens Medical, Terumo, and Translumina.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi, Terumo, Medtronic.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.

    Francesco Maisano has declared to have potential conflicts of interest to report : Grant Institute, Edwards, Abbott, NVT, Medtronic, Jenavalve and Boston Scientifics.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology this Week: A concise summary of recent studies

    Coronary artery calcium scoring

    Checklists in aviation and in medicine

    Mythbusters: Being married reduces cardiovascular mortality

    Host: Susanna Price

    Guests: Thomas Achenbach, Carlos Aguiar, Michael Blaha, Edward Nicol

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1154

    Disclaimer

    ESC TV Today and ESC 365, the cardiology knowledge hub are supported by Bristol Myers Squibb. The scientific content and opinions expressed in this programme have not been influenced in any way by its sponsor.

    This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Thomas Achenbach, Michael Blaha, Edward Nicol, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies Genetic testing in dilated cardiomyopathy Gut microbiome and heart disease Mythbusters: Sitting is the new smoking

    Host: Rick Grobbee

    Guests: Carlos Aguiar, Arash Haghikia and Juan Pablo Kaski

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1153

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Rick Grobbee, Arash Haghikia, Juan Pablo Kaski and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies

    State-of-affairs in hypertension treatment

    Anticoagulation in pregnancy

    Statistics Made Easy : Accuracy and AUC

    Host: Perry Elliott

    Guests: Carlos Aguiar, Gianfranco Parati, Julie De Backer

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1152

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Julie De Backer and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Perry Elliott has declared to have potential conflicts of interest to report: consultancies for Pfizer, BMS, Cytokinetics.

    Gianfranco Parati has declared to have potential conflicts of interest to report: honoraria for lectures by Omron, Viatris, Merck, Recor, Somnomedics.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies

    Long-term beta blockers after myocardial infarction

    Pros and Cons of the microaxial pump in cardiogenic shock

    Snapshots

    Host: Perry Elliott

    Guests: Stephan Achenbach, Carlos Aguiar, Michael Boehm, Lene Holmvang

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1151

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Michael Boehm, Lene Holmvang and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies All you need to know about omega-3 fatty acids Lead induced tricuspid regurgitation MythBusters: Pomegranates are heart-healthy

    Host: Rick Grobbee

    Guests: Carlos Aguiar, Martin Andreas, Deepak Bhatt

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1150

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Martin Andreas has declared to have potential conflicts of interest to report: proctor/speaker/consultant (Edwards, Abbott, Medtronic, Boston, Braun, Zoll) and institutional Research Grants (Edwards, Abbott, Medtronic, LSI).

    Deepak Bhatt has declared to have potential conflicts of interest to report: research funding from Amarin paid to Brigham and Women’s Hospital and the Icahn School of Medicine at Mount Sinai for my role as Principal Investigator of REDUCE-IT.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies MINOCA Long QT Syndrome Statistics Made Easy: subgroup analyses and tests for interaction

    Host: Rick Grobbee

    Guests: Carlos Aguiar, Martha Gulati, Dieter Nuyens

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1149

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Rick Grobbee, Martha Gulati, Nicolle Kraenkel and Dieter Nuyens have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Novo Nordisk, Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies Microplastics and nanoplastics in atheromas and cardiovascular events Leadless pacemakers Snapshots

    Host: Rick Grobbee

    Guests: Stephan Achenbach, Carlos Aguiar, Emanuele Barbato, Haran Burri

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1148

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Emanuele Barbato, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Haran Burri has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.

  • ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

    This episode covers:

    Cardiology This Week: A concise summary of recent studies Immune checkpoint inhibitors and the heart HDL, HDL therapies and cardiovascular risk Diagnostics Made Easy: the FBI syndrome

    Host: Susanna Price

    Guests: Carlos Aguiar, Alexander Lyon, Francois Mach

    Want to watch that episode? Go to: https://esc365.escardio.org/event/1147

    Disclaimer

    This programme is intended for health care professionals only and is to be used for educational purposes.

    The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.

    Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

    Declarations of interests

    Stephan Achenbach, Francois Mach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report.

    Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.

    Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Novo Nordisk, Sanofi. Terumo, Medtronic.

    Alexander Lyon has declared to receive speaker, advisory board or consultancy fees and/or research grants from Janssens-Cilag Ltd, Astellas Pharma, Pfizer, Novartis, Servier, Astra Zeneca, Bristol Myers Squibb, GSK, Amgen, Takeda, Roche, Clinigen Group, Eli Lily, Eisai Ltd, Ferring Pharmaceuticals, Boehringer Ingelheim, Akcea Therapeutics, Myocardial Solutions, iOWNA Health and Heartfelt Technologies Ltd.

    Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer-Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.